PatternsRadar
Sign in

SHILPAMEDShilpa Medicare Limited

NSEASM Stage I
849.15INR-51.55 (-5.72%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹16,608 CrMarket cap
50.0P/E (TTM)
46.1%Delivery

Filings & corporate actions

70 results filed
CSV
Next results · Q3 FY27
Expected 6 Feb 2027 – 15 Feb 2027
Estimate: filed 37–46 days after quarter end, last 5 times
Dividend
₹0.60 per share · last 4 Sept 2026
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone-1.0%NSE
  • 7 OctshareholdingShareholding · 30 Sept 2026-0.2%NSE
  • 4 SeptdividendDividend · ₹0.60 per share+0.8%
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone+12.0%NSE
  • 13 JulshareholdingShareholding · 30 Jun 2026+0.5%NSE
  • 22 MayresultsResults · Q4 FY26 · consolidated and standalone+4.5%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026+3.8%NSE
  • 6 FebresultsResults · Q3 FY26 · consolidated and standalone+5.3%NSE
  • 12 JanshareholdingShareholding · 31 Dec 2025-1.3%NSE

Reaction to results · all yearsrose on day 0 in 31 of 68 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026-1.0%+6.3%—2.8×
Q1 FY275 Aug 2026+12.0%+24.9%+44.0%28.2×
Q4 FY2622 May 2026+4.5%+5.5%+20.6%4.8×
Q3 FY266 Feb 2026+5.3%+4.3%+7.2%4.0×
Q2 FY2613 Nov 2025-2.8%-10.2%-15.2%1.0×
Q1 FY2613 Aug 2025+0.3%-6.0%-9.0%2.2×
Q4 FY2526 May 2025-1.8%-1.7%-2.9%3.5×
Q3 FY2511 Feb 2025-4.1%-7.3%-6.9%1.1×
Q2 FY2514 Nov 2024+5.9%+8.8%-1.7%4.7×
Q1 FY259 Aug 2024-0.6%-2.5%+17.8%1.1×
Q4 FY2424 May 2024-1.5%-3.5%+17.8%1.0×
Q3 FY249 Feb 2024-4.0%-1.1%+10.0%3.4×
Q2 FY2410 Nov 2023-0.5%-1.8%-1.3%0.5×
Q1 FY2410 Aug 2023+0.3%+6.9%+5.9%0.5×
Q4 FY2326 May 2023-2.9%-3.2%+1.9%1.7×
Q3 FY2315 Feb 2023-0.2%+16.4%+1.3%1.1×
Q2 FY2312 Nov 2022-2.5%-4.5%-1.1%2.9×
Q1 FY2312 Aug 2022-1.2%-1.5%-2.2%1.1×
Q4 FY2224 May 2022-4.7%-3.9%-7.7%1.1×
Q3 FY229 Feb 2022-5.1%-6.0%-13.3%1.6×
Q2 FY2230 Oct 2021+2.2%+0.5%-3.2%1.0×
Q1 FY2214 Aug 2021-4.9%-5.3%-1.7%0.8×
Q4 FY211 Jun 2021-4.6%+9.6%+6.4%0.9×
Q3 FY2113 Feb 2021-1.1%-14.9%-18.5%3.7×
Q2 FY213 Nov 2020+1.6%+0.1%+9.9%0.7×
Q1 FY218 Aug 2020+11.0%+3.4%-10.1%6.2×
Q4 FY2018 Jun 2020-1.6%-6.8%-1.9%0.3×
Q3 FY2011 Feb 2020+10.0%+10.3%-1.3%3.5×
Q2 FY2010 Nov 2019+2.1%-7.9%-10.5%3.5×
Q1 FY2014 Aug 2019-16.9%-24.1%-20.4%5.3×
Q4 FY1928 May 2019-5.8%-7.6%-9.4%4.8×
Q3 FY1913 Feb 2019-1.3%-1.9%+2.3%0.4×
Q2 FY1922 Nov 2018-0.6%-1.0%0.0%0.3×
Q1 FY1931 Aug 2018+0.8%-1.9%-18.4%0.6×
Q4 FY1826 Jun 2018-1.8%-4.6%-3.5%0.5×
Q3 FY1822 Feb 2018+1.7%-7.7%+9.1%0.7×
Q2 FY1821 Nov 2017+4.3%+6.8%+0.4%1.3×
Q1 FY1821 Aug 20170.0%+9.7%+4.9%0.4×
Q4 FY1715 Jun 2017-0.1%-0.9%+6.3%0.2×
Q3 FY1715 Feb 2017-2.5%-0.5%-0.7%2.3×
Q2 FY1729 Nov 2016+4.9%-1.9%+5.4%1.6×
Q1 FY173 Oct 2016+11.2%+6.7%+8.8%10.8×
Q4 FY1630 May 2016+5.7%+3.9%+10.4%3.2×
Q3 FY1613 Feb 2016+3.7%+2.7%+6.0%1.0×
Q2 FY169 Nov 2015+2.6%+13.3%-4.9%1.0×
Q1 FY1610 Aug 2015+1.7%+0.2%-13.9%2.6×
Q4 FY154 Jun 2015-0.5%-6.1%-5.5%0.2×
Q3 FY1518 Feb 2015-1.9%-9.4%+11.1%0.5×
Q2 FY1522 Nov 20140.0%-2.5%+12.7%0.5×
Q1 FY1520 Aug 2014+1.1%-1.4%+2.1%2.8×
Q4 FY1429 May 2014+1.7%0.0%+0.1%3.9×
Q3 FY1411 Feb 20140.0%+6.3%+8.2%2.6×
Q2 FY1412 Nov 2013+1.2%+4.1%+12.4%1.2×
Q1 FY1416 Aug 2013+2.6%+0.8%-0.3%1.2×
Q4 FY136 Jun 2013+1.1%-0.9%+0.4%0.2×
Q3 FY1312 Feb 2013+1.9%+3.9%-1.2%1.5×
Q2 FY137 Nov 2012+1.4%+0.9%+5.6%1.1×
Q1 FY1313 Aug 2012+1.0%+10.2%+8.6%0.7×
Q4 FY1216 May 2012-0.6%+13.4%+5.1%0.1×
Q3 FY1210 Feb 2012-5.1%-3.5%+0.3%1.4×
Q2 FY1218 Nov 2011+2.6%-5.7%-23.0%0.2×
Q1 FY1219 Aug 2011+1.3%+3.6%+9.7%0.4×
Q4 FY1112 May 2011-0.1%-1.0%-1.2%1.2×
Q3 FY1128 Jan 2011-2.5%-2.4%-2.9%0.5×
Q2 FY1127 Oct 2010-3.3%-9.7%-21.8%2.1×
Q1 FY1128 Jul 2010-0.7%+8.0%+3.6%2.5×
Q4 FY1029 Apr 2010+3.1%-1.3%-12.5%0.2×
Q3 FY1025 Jan 2010-0.8%-7.9%-9.3%0.3×
Average+0.3%-0.0%+0.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+43.0%
Profit YoY+79.7%
Interest cost YoY-19.1%
Revenue QoQ+13.6%
Profit QoQ-21.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+23.1%+18.8%+12.8%—+11.5%—
Profit+133.1%—+95.4%—+7.0%—

Key data

Open854.30
Day range836.70 – 890.00
52-week range259.50 – 1,095.00
From 52w high-22.5%
RSI (14)35.4
ATR (14)49.67
Volume15.39L
Avg volume (20D)7.51L
Rel volume2.05×
Volatility (1Y)43.7%
Turnover₹131.9Cr
Traded value (NSE)₹131.9Cr
VWAP857.16
SMA 50 / 200962.38 / 631.75
Price band20%

Delivery percentage

Latest · 20 Nov 202646.1%
20-day avg45.1%
1-year avg45.5%
Percentile (own history)30th
Range2.0–100.0%
Sessions3,628

Over the last 20 sessions SHILPAMED settled 45.1% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 45.5%. The latest session ranks higher than 30% of the 3,628 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.07%
Dividend, trailing 12M₹0.60
Paid every year for2 yr
Shareholders87.5K · +43.6% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy106 days ago

Performance returns

1D1W1M3M6M1Y
Price-5.72%-14.36%-1.35%+3.44%+78.90%+123.70%

Valuation

Market cap₹16,608 Cr
Market cap (NSE)₹16,608 Cr
Free-float cap₹9,943 Cr
P/E (TTM)50.0
P/E (NSE)53.0
EPS (TTM)17.00
P/B6.0
Net margin (TTM)18.1%
Other income / PBT3.8%
ROE12.8%
Debt / equity0.24
Shares outstanding19.56Cr
Listed3 Dec 2009

Ownership

Promoter40.13%
Promoter Δ QoQ0.00 pp
Public59.87%
FII12.11%
DII8.26%
Pledged4.90%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)409.7437.0465.8529.1
YoY chg+28.3%+32.1%+44.9%+43.0%
Net profit (₹ Cr)44.6107.8100.979.2
YoY chg+40.3%+642.9%+115.2%+79.7%
Net margin10.9%24.7%21.7%15.0%
EPS2.365.515.164.05

Shareholding over time

By quarter

30 Sept 2026 · promoter 40.13% · public 59.87%
30 Sept 2021: promoter 53.25%12 Nov 2021: promoter 50.01%31 Dec 2021: promoter 50.01%31 Mar 2022: promoter 50.01%30 Jun 2022: promoter 50.01%30 Sept 2022: promoter 50.01%31 Dec 2022: promoter 50.01%31 Mar 2023: promoter 50.01%30 Jun 2023: promoter 50.01%30 Sept 2023: promoter 50.01%31 Dec 2023: promoter 50.01%31 Mar 2024: promoter 50.01%13 Apr 2024: promoter 44.39%30 Jun 2024: promoter 44.39%30 Sept 2024: promoter 44.33%31 Dec 2024: promoter 44.23%31 Mar 2025: promoter 44.23%30 Jun 2025: promoter 44.23%30 Sept 2025: promoter 44.23%31 Dec 2025: promoter 40.13%31 Mar 2026: promoter 40.13%30 Jun 2026: promoter 40.13%30 Sept 2026: promoter 40.13%
2021-092026-09
  • Promoter
  • Public and others
Promoter
40.13%
Public
59.87%
Promoter change
0.00 pp
Filed
7 Oct 2026
FII
12.11%
DII
8.26%
Promoter pledged
4.90%

Who the public is

Mutual funds
4.20%

-0.01 pp QoQ

Insurance
2.56%

+0.25 pp QoQ

FPI
12.11%

+0.72 pp QoQ

Retail ≤ ₹2L
16.86%

+0.42 pp QoQ

HNI > ₹2L
10.88%

-0.35 pp QoQ

NRI
2.74%

+0.07 pp QoQ

Bodies corporate
7.79%

-1.00 pp QoQ

Shareholders
87,477

+43.6% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
VISHNUKANT CHATURBHUJ BHUTADAPromoter · Individual6.51%
DHARMAVATI BHUTADAPromoter · Individual6.35%
RAVI KUMAR INNANIPromoter · Individual4.10%
SURAJ KUMAR INANIIndividual4.01%
OM PRAKASH INANIPromoter · Individual2.93%
DEEPAK KUMAR INNANIPromoter · Individual2.80%
KANTADEVI INANIPromoter · Individual2.60%
SBI LIFE INSURANCE CO. LTDInsurance2.56%
SUNIDHI CAPITAL PRIVATE LIMITEDCorporate2.25%
COHESION MK BEST IDEAS SUB-TRUSTFPI2.07%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 17 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.60₹0.60
FY2025-261₹1.00₹0.50
FY2022-231₹1.10₹0.55
FY2021-221₹1.10₹0.55
FY2019-202₹2.10₹1.05
FY2017-181₹0.70₹0.35
FY2016-171₹0.60₹0.30
FY2015-162₹1.70₹0.57
FY2014-151₹1.00₹0.25
FY2013-141₹1.30₹0.33
FY2012-131₹0.90₹0.15
Ex-dateRecord dateDeclaredAdjusted
4 Sept 2026—₹0.60₹0.60
17 Sept 2025—₹1.00₹0.50
19 Sept 2022—₹1.10₹0.55
20 Sept 2021—₹1.10₹0.55
16 Mar 2020—₹1.10₹0.55
12 Sept 2019—₹1.00₹0.50
1 Mar 2018—₹0.70₹0.35
21 Mar 2017—₹0.60₹0.30
28 Mar 2016—₹0.60₹0.30
16 Sept 2015—₹1.10₹0.28
11 Sept 2014—₹1.00₹0.25
16 Jul 2013—₹1.30₹0.33
17 Sept 2012—₹0.90₹0.15

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
−₹42.0L
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
4.1 years ago
Disclosures on record
110
14 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
29 Sept 2026Alpesh Maheshkumar DalalKMPSell4.0K₹42.0L1,050.004.0K → 00.00%7(2)told 29 Sept 2026
13 Dec 2024PRIYA INANIPromoterSell1.00L₹8.4Cr837.451.81L → 80.7K0.08%-0.10 pp7(2)told 12 Dec 2024
27 Aug 2024MR.SURAJ KUMAR INANIPromoterSell50.0K₹3.8Cr760.8139.71L → 39.21L4.01%-0.05 pp7(2)told 26 Aug 2024
26 Aug 2024Mr. Suraj Kumar InaniPromoterSell10.0K₹70.0L700.0339.81L → 39.71L4.06%-0.01 pp7(2)told 24 Aug 2024
19 Dec 2023RAKESH KUMAR DOBAOtherSell44~₹16,210368.405.8K → —0.00%7(2)told 18 Dec 2023
19 Dec 2023RAKESH KUMAR DOBAOtherSell5.7K~₹21.1L368.405.8K → —0.00%7(2)told 18 Dec 2023
21 Oct 2022Mr. Suraj Kumar InnaniPromoterSell3.0K₹10.1L335.7739.84L → 39.81L4.59%-0.00 pp7(2)told 20 Oct 2022
21 Oct 2022Mr. Suraj Kumar InnaniPromoterBuy3.0K₹10.2L339.8839.81L → 39.84L4.59%+0.00 pp7(2)told 20 Oct 2022
18 Nov 2021ALPESH MAHESHKUMAR DALALKMPBuy2.0K~₹11.3L565.30— → 2.0K0.00%7(2)told 17 Nov 2021
28 Aug 2020OMPRAKASH INANIPromoterSell1.39L₹8.3Cr601.6430.06L → 28.68L3.52%-0.17 pp7(2)told 27 Aug 2020
27 Aug 2020OMPRAKASH INANIPromoterSell65.7K₹3.9Cr598.8230.72L → 30.06L3.69%-0.08 pp7(2)told 26 Aug 2020
25 Aug 2020RAMAKANT INANIPromoterSell18.5K₹1.1Cr597.9935.16L → 34.98L4.29%-0.02 pp7(2)told 24 Aug 2020
25 Aug 2020RAMAKANT INANIPromoterSell2.32L₹13.9Cr598.3737.48L → 35.16L4.31%-0.28 pp7(2)told 21 Aug 2020
14 Mar 2018RAMAKANT INANIPromoterBuy5.00L~₹20.4Cr407.0010.48L → 15.48L1.90%+0.61 pp7(2)told 12 Mar 2018

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 6 Aug 2026

CSV
12 of 95 deals
By year
DateDealClientQuantityPriceValue
6 Aug 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED10.78L760.04₹81.9Cr
6 Aug 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED10.78L759.36₹81.8Cr
5 Aug 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED11.03L723.16₹79.8Cr
5 Aug 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED11.03L722.79₹79.7Cr
21 Mar 2025Buy · bulkTHE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND5.48L683.03₹37.4Cr
23 Jan 2025Buy · blockUBS AG1.63L818.05₹13.3Cr
23 Jan 2025Sell · blockUBS PRINCIPAL CAPITAL ASIA LIMITED1.63L818.05₹13.3Cr
5 Jun 2024Buy · bulkPLUTUS WEALTH MANAGEMENT LLP7.50L492.34₹36.9Cr
21 Feb 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.83L444.09₹21.4Cr
21 Feb 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.83L443.95₹21.4Cr
20 Feb 2024Sell · bulkTA FII INVESTORS LIMITED5.00L422.22₹21.1Cr
19 Feb 2024Sell · bulkTA FII INVESTORS LIMITED13.45L407.05₹54.7Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 25 Aug 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.
  • P/E > 50 (4 quarters) · since 11 Aug 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations286.5291.7292.5343.8319.3330.8321.5370.0409.7437.0465.8529.1
Other income2.22.59.45.01.17.66.41.80.81.73.18.7
Total income288.7294.2302.0348.8320.4338.4327.8371.7410.5438.7468.9537.8
Total expenses273.5272.5269.8311.6279.2297.3277.5307.2336.5361.6376.8433.7
└ Finance costs26.224.223.725.611.714.518.815.710.713.712.112.7
└ Depreciation26.726.627.128.328.828.828.929.830.430.635.234.3
Profit before tax15.227.932.237.241.313.050.364.561.2120.592.1103.5
Tax expense9.53.214.618.89.80.82.720.416.312.7(2.8)24.3
Net profit4.724.514.117.931.814.546.944.144.6107.8100.979.2
EPS0.271.410.730.921.630.742.401.132.365.515.164.05
Net margin1.64%8.40%4.81%5.22%9.95%4.39%14.59%11.91%10.88%24.67%21.66%14.97%
PBT margin5.32%9.55%11.01%10.81%12.92%3.92%15.65%17.45%14.94%27.56%19.77%19.57%
Tax rate62.13%11.53%45.40%50.67%23.81%5.90%5.36%31.55%26.58%10.51%-3.07%23.51%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets2,902.43,004.03,093.23,117.33,310.73,495.13,705.64,137.6
Current assets768.0825.1876.8859.0985.71,039.71,109.81,277.2
└ Cash & equivalents21.323.730.217.026.018.041.344.7
└ Other bank balances0.20.20.20.22.64.03.94.9
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables324.3355.4392.0359.8440.8426.9518.9535.8
└ Inventories319.8331.6344.9326.6347.9444.9366.8442.5
Total equity1,774.41,774.61,800.02,319.22,363.72,438.52,591.22,757.7
└ Attributable to owners1,783.31,783.51,808.72,327.92,372.22,437.22,591.22,757.7
└ Non-controlling interest(8.9)(8.9)(8.7)(8.7)(8.5)1.3——
└ Share capital8.78.78.79.89.89.819.619.6
Borrowings795.7863.5935.6490.6586.4591.3658.0664.4
└ Current506.9306.7375.4225.1354.4401.7474.2441.5
└ Non-current288.8556.8560.2265.5232.0189.6183.8222.8
Trade payables144.4184.8174.897.195.4165.0142.5266.0
Current liabilities782.9630.2693.3494.5674.2780.3848.11,016.5
Total liabilities1,128.01,229.41,293.2798.1947.01,056.61,114.41,379.9
Net debt774.2839.5905.2473.4557.8569.3612.8614.7
Debt / equity0.450.490.520.210.250.240.250.24
Current ratio0.981.311.261.741.461.331.311.26

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow226.286.3135.3105.2132.2201.2342.2292.2
└ Capex(272.5)(107.9)(184.6)(119.3)(243.6)(162.7)(370.6)(260.8)
Free cash flow(46.4)(21.6)(49.2)(14.0)(111.5)38.5(28.5)31.5
Investing cash flow(278.5)(104.0)(166.6)(107.4)(199.1)(170.6)(325.9)(254.9)
Financing cash flow45.824.246.8(8.4)62.7(30.2)13.6(30.0)
└ Dividends paid(9.5)0.00.00.00.0(9.8)(9.8)(11.2)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(6.5)6.515.5(10.6)(4.3)0.329.97.3

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SHILPAMED at a glance

  • SHILPAMED closed at ₹849.15 on 20 Nov 2026, -5.72% on the day, +123.7% over one year, 22.5% below its 52-week high of ₹1,095.
  • Delivery was 46.1% of traded quantity on 20 Nov 2026, the 30th percentile of its own 3,628 sessions with a reading (20-session average 45.1%, 1-year average 45.5%).
  • Market capitalisation is ₹16,608 crore at a trailing P/E of 50.0 (trailing EPS ₹17).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹529 crore (+43.0% year on year), net profit ₹79 crore (+79.7%); the price moved -1.0% on the first session after.
  • Promoters held 40.13% at 30 Sept 2026, unchanged on the previous filing, with 4.90% of promoter shares pledged.
  • Q3 FY27 results are expected between 6 Feb 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE790G01031
SeriesEQ
Listed3 Dec 2009
NSE market cap · 17 Nov 2026₹17,941 Cr
Free-float market cap (NSE)₹10,687 Cr
Shares outstanding (NSE)19.56Cr
History from3 Dec 2009
Sessions4,204
Turnover rank#360

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.